Mga Batayang Estadistika
| CIK | 1026650 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Eresearchtechnology Inc
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| February 11, 2013 |
ERT / Eresearchtechnology Inc / VANGUARD GROUP INC Passive Investment SC 13G/A 1 eresearchtechnologyinc.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1 )* Name of issuer: eResearch Technology Inc Title of Class of Securities: COMMON STOCK CUSIP Number: 29481V108 Date of Event Which Requires Filing of this Statement: December 31, 2012 Check the appropriate box to designate the rule |
|
| January 31, 2013 |
ERT / Eresearchtechnology Inc / TOCQUEVILLE ASSET MANAGEMENT L.P. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* eResearch Technology, Inc. (Name of Issuer) Common Stocks (Title of Class of Securities) 29481V108 (CUSIP Number) Calendar Year 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p |
|
| August 8, 2012 |
ERT / Eresearchtechnology Inc / COLUMBIA WANGER ASSET MANAGEMENT LLC - SC 13G/A Passive Investment SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 7)* ERESEARCH TECHNOLOGY INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) July 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursuant to which this Schedul |
|
| July 13, 2012 |
FORM 15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 0-29100 eResearchTechnology, Inc. (Exact name of registrant as speci |
|
| July 9, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 3, 2012 eResearchTechnology, Inc. (Exact name of Registrant as specified in Charter) Delaware 0-29100 22-3264604 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| July 9, 2012 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ERESEARCHTECHNOLOGY, INC. ARTICLE I EX-3.1 3 d376369dex31.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ERESEARCHTECHNOLOGY, INC. ARTICLE I The name of the corporation (the “Corporation”) is “eResearchTechnology, Inc.” ARTICLE II The address of the Corporation’s registered office in the State of Delaware is 1209 Orange Street in the City of Wilmington, County of New Castle, 19801. The name of its regist |
|
| July 9, 2012 |
EX-99.2 Exhibit 99.2 ERT Acquires invivodata to Establish the Industry’s Most Experienced Provider of Clinical Outcome Assessment Solutions PHILADELPHIA, PA, July 9 2012 /PRNewswire/ - ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and Contract Research Organizations (CROs), announced today the acquisition of invivodata, Inc, a leading provider o |
|
| July 9, 2012 |
EX-2.2 Exhibit 2.2 AGREEMENT AND PLAN OF MERGER BY AND AMONG EXPLORER HOLDINGS, INC. EXPLORER ACQUISITION CORP., IMPACT ACQUISITION CORP., INVIVODATA, INC., AND FORTIS ADVISORS LLC, AS THE STOCKHOLDER REPRESENTATIVE, June 29, 2012 TABLE OF CONTENTS PAGE Article 1. Definitions 2 Section 1.01 Definitions 2 Section 1.02 Definitional and Interpretative Provisions 12 Article 2. The Merger 13 Section 2. |
|
| July 9, 2012 |
EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ERESEARCHTECHNOLOGY, INC. (a Delaware corporation) Adopted as of July 3, 2012 TABLE OF CONTENTS Page ARTICLE I. IDENTIFICATION; OFFICES 1 Section 1. NAME 1 Section 2. PRINCIPAL AND BUSINESS OFFICES 1 Section 3. REGISTERED AGENT AND OFFICE 1 Section 4. PLACE OF KEEPING CORPORATE RECORDS 1 ARTICLE II. STOCKHOLDERS 1 Section 1. ANNUAL MEETING 1 Sectio |
|
| July 9, 2012 |
Genstar Capital Completes ERT Acquisition In A Take-Private Transaction EX-99.1 Exhibit 99.1 Genstar Capital Completes ERT Acquisition In A Take-Private Transaction PHILADELPHIA, July 3, 2012/PRNewswire/—ERT (Nasdaq: ERT), a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations (CROs), announced today that Genstar Capital, LLC, has completed its acquisition of the company in a take-private trans |
|
| July 9, 2012 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 3, 2012 eResearchTechnology, Inc. (Exact name of Registrant as specified in Charter) Delaware 0-29100 22-3264604 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| July 3, 2012 |
S-8 POS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction of Incorporation or Organization) |
|
| July 3, 2012 |
S-8 POS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction of Incorporation or Organization) |
|
| July 3, 2012 |
S-8 POS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction of Incorporation or Organization) |
|
| July 3, 2012 |
POS AM UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction of Incorporation or Organization) ( |
|
| July 3, 2012 |
- POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction |
|
| July 3, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction of Incorporation or Organization) (Address |
|
| July 3, 2012 |
S-8 POS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction of Incorporation or Organization) |
|
| July 3, 2012 |
S-8 POS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction of Incorporation or Organization) |
|
| June 22, 2012 |
ERT Announces Stockholder Approval of Merger Press Release Exhibit 99.1 ERT Announces Stockholder Approval of Merger PHILADELPHIA, June 22, 2012 – eResearchTechnology, Inc. (Nasdaq: ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations, announced today that at a special meeting of stockholders held this morning, its stockholders approved, among other t |
|
| June 22, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 22, 2012 eResearchTechnology, Inc. |
|
| June 12, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15( D ) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of Report (Date of earliest reported): June 12, 2012 eResearchTechnology, Inc. |
|
| May 21, 2012 |
- DEFINITIVE PROXY MATERIALS - ERESEARCHTECHNOLOGY, INC Definitive Proxy Materials - eResearchTechnology, Inc Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 9, 2012 |
- ERESEARCHTECHNOLOGY, INC. PRELIMINARY PROXY STATEMENT eResearchTechnology, Inc. Preliminary Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement. ¨ Confidential, for use of the Co |
|
| May 7, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 7, 2012 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commi |
|
| May 7, 2012 |
Press Release Exhibit 99.1 ERT Reports First Quarter 2012 Operating Results • Revenues of $50.5 million • GAAP diluted net income per share of $0.08 / Non-GAAP diluted net income per share of $0.10 • Bookings of $76.3 million PHILADELPHIA, May 7, 2012 /PRNewswire-FirstCall/ — eResearchTechnology, Inc. (ERT), (Nasdaq: ERT—News), a global technology-driven provider of health outcomes research servic |
|
| May 7, 2012 |
Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 7, 2012 |
Preamble—Omitted § 1 Rented property EX-10.21 3 d338851dex1021.htm EX-10.21 Exhibit 10.21 Pursuant to Rule 12b-12(d)(3), set forth below is an English language summary of the Lease Agreement, dated February 2, 2012, between eResearchTechnology GmbH and KHF Grundbesitz GmbH & Co KG, the original of which is in German, including a summary of the material provisions thereof and a description of the provisions omitted from the summary. P |
|
| May 7, 2012 |
eResearchTechnology, Inc. 2012 Bonus Plan EX-10.13 2 d338851dex1013.htm EX-10.13 Exhibit 10.13 eResearchTechnology, Inc. 2012 Bonus Plan Set forth below is a summary of the eResearchTechnology, Inc. (“ERT” or the “Company”) 2012 Bonus Plan (the “2012 Plan”) approved by the Compensation Committee at its meeting on February 24, 2012, which was effective January 1, 2012. The purpose of the 2012 Plan is to promote the interests of the Company |
|
| May 4, 2012 |
Entry into a Material Definitive Agreement - FORM 8-K FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 1, 2012 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commi |
|
| April 30, 2012 |
Employment Agreement Effective May 26, 1998 Exhibit 10.47 [English translation of agreement originally executed in German] Employment Agreement for Managerial Employee Between ERICH JAEGER GmbH, 97204 Höchberg, Leibnizstraße 7, - hereinafter referred to as “the Firm” - and Mr. Hans-Joachim Schülke, born 10.05.1961, 97320 Mainstockheim, Am Haselberg 16 - hereinafter referred to as “the Employee” - |
|
| April 30, 2012 |
Amendment to Management Employment Agreement Amendment to Management Employment Agreement Effective December 2010 Exhibit 10.49 Amendment to Management Employment Agreement This Agreement to Management Employment Agreement (the “Amendment”) is hereby entered into between John Sory (hereinafter known as the “Employee”) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the “Company”): 1. TERM; TERMIN |
|
| April 30, 2012 |
MANAGEMENT EMPLOYMENT AGREEMENT Management Employment Agreement Effective November 10, 2009 Exhibit 10.48 MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as “Agreement”) is hereby entered into between John Sory (hereinafter known as “Employee”) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the “Company”) and having its principal offices at 1818 Market Str |
|
| April 30, 2012 |
Annual Report - FORM 10-K AMENDMENT NO. 1 Form 10-K Amendment No. 1 Table of Contents United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2011 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fro |
|
| April 30, 2012 |
Letter Agreement Dated May 17, 2010 Exhbit 10.50 May 17, 2010 Achim, As you know the shares in Research Services Germany 234 GmbH will be transferred to a German affiliate of eResearch Technology, Inc., presumably at the end of this month. We are pleased to inform you that we as the new shareholder will safeguard that your salary to be received from Research Services Germany 234 GmbH will be 200,0 |
|
| April 10, 2012 |
ERT Announces Acquisition by Genstar Capital Press Release issued by eResearch technology, Inc. on April 10, 2012 Exhibit 99.1 ERT Announces Acquisition by Genstar Capital PHILADELPHIA, April 10, 2012 – eResearchTechnology, Inc. (ERT), (Nasdaq: ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs), today announced that it has entered into a defi |
|
| April 10, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of Report (Date of earliest reported): April 9, 2012 eResearchTechnology, Inc. |
|
| April 10, 2012 |
Consulting Agreement dated April 10, 2012 Exhibit 10.1 EXECUTION COPY CONSULTING AGREEMENT This CONSULTING AGREEMENT (“Agreement) is made by and between Joel Morganroth, M.D., P.C., a Pennsylvania professional corporation (“Consultant”), and eResearchTechnology, Inc., a Delaware corporation (“Company”), as of April 9, 2012. WHEREAS, in connection with the consummation of the transactions described |
|
| April 10, 2012 |
EX-10.1 3 d333775dex101.htm CONSULTING AGREEMENT DATED APRIL 10, 2012 Exhibit 10.1 EXECUTION COPY CONSULTING AGREEMENT This CONSULTING AGREEMENT (“Agreement) is made by and between Joel Morganroth, M.D., P.C., a Pennsylvania professional corporation (“Consultant”), and eResearchTechnology, Inc., a Delaware corporation (“Company”), as of April 9, 2012. WHEREAS, in connection with the consummation o |
|
| April 10, 2012 |
ERT Announces Acquisition by Genstar Capital Press Release issued by eResearch technology, Inc. on April 10, 2012 Exhibit 99.1 ERT Announces Acquisition by Genstar Capital PHILADELPHIA, April 10, 2012 – eResearchTechnology, Inc. (ERT), (Nasdaq: ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs), today announced that it has entered into a defi |
|
| April 10, 2012 |
Agreement and Plan of Merger by and among Explorer Holdings, Inc dated 4/9/2012 Exhibit 2. |
|
| April 10, 2012 |
DEFA14A 1 d333775d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of Report (Date of earliest reported): April 9, 2012 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 0- |
|
| April 10, 2012 |
Employee FAQ regarding the Merger Exhibit 99.2 To: All ERT Staff From: Jeffrey Litwin – President & CEO Date: April 10, 2012 Subject: ERT Announces Acquisition by Genstar To the entire ERT Team: Today we have announced a definitive agreement for the acquisition of ERT by Genstar Capital, a private equity firm based in California. Many of you will already have seen the public press release which wa |
|
| April 10, 2012 |
Employee FAQ regarding the Merger Exhibit 99.2 To: All ERT Staff From: Jeffrey Litwin – President & CEO Date: April 10, 2012 Subject: ERT Announces Acquisition by Genstar To the entire ERT Team: Today we have announced a definitive agreement for the acquisition of ERT by Genstar Capital, a private equity firm based in California. Many of you will already have seen the public press release which wa |
|
| April 10, 2012 |
Agreement and Plan of Merger by and among Explorer Holdings, Inc dated 4/9/2012 Exhibit 2. |
|
| March 2, 2012 |
eResearchTechnology, Inc. Statement of Computation of Ratio of Earnings to Fixed Charges Statement of Computation of Ratio of Earnings to Fixed Charges Exhibit 12.1 eResearchTechnology, Inc. Statement of Computation of Ratio of Earnings to Fixed Charges The following table sets forth our ratio of earnings to fixed charges for the period indicated: Year Ended December 31, 2007 2008 2009 2010 2011 (dollars in thousands) Income before income taxes $ 24,457 $ 40,125 $ 17,478 $ 14,422 $ 18 |
|
| March 2, 2012 |
eResearchTechnology, Inc. 2011 Bonus Plan Bonus Plan Exhibit 10.14 eResearchTechnology, Inc. 2011 Bonus Plan Set forth below is a summary of the eResearchTechnology, Inc. (“ERT” or the “Company”) 2011 Bonus Plan (the “2011 Plan”) approved by the Compensation Committee and ratified by the Board of Directors at their respective meetings on December 7, 2010, to be effective for fiscal 2011. The purpose of the 2011 Plan is to promote the inte |
|
| March 2, 2012 |
FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 1, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 24, 2012 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) |
|
| February 27, 2012 |
EX-99.1 Exhibit 99.1 ERT Reports Fourth Quarter and Full Year 2011 Operating Results • Record revenues of $52.3 million for the fourth quarter and $184.9 million for the full year 2011 • GAAP diluted net income per share of $0.09 for the fourth quarter / Non-GAAP diluted net income per share of $0.14 for the fourth quarter • Record bookings of $82.5 million for the fourth quarter / $303.5 million |
|
| February 27, 2012 |
FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2012 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) |
|
| February 13, 2012 |
EXHIBIT 99.1 - JOINT FILING AGREEMENT Joint Filing Agreement Exhibit 99.1 EXHIBIT 99.1 - JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is respo |
|
| February 13, 2012 |
Schedule 13G Amendment No. 6 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 6)* ERESEARCH TECHNOLOGY INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursua |
|
| February 9, 2012 |
ERT / Eresearchtechnology Inc / VANGUARD GROUP INC Passive Investment eresearchtechnologyinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.:0 )* Name of issuer: eResearchTechnology Inc Title of Class of Securities: Common Stock CUSIP Number: 29481V108 Date of Event Which Requires Filing of this Statement: December 31, 2011 Check the approp |
|
| February 6, 2012 |
Entry into a Material Definitive Agreement - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 31, 2012 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) ( |
|
| January 30, 2012 |
ERT / Eresearchtechnology Inc / TOCQUEVILLE ASSET MANAGEMENT L.P. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* eResearch Technology, Inc. (Name of Issuer) Common Stocks (Title of Class of Securities) 29481V108 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu |
|
| December 9, 2011 |
Correspondence December 9, 2011 VIA EDGAR Securities and Exchange Commission 100 F Street, N. |
|
| November 7, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) þ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2011 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file num |
|
| November 7, 2011 |
Exhibit 2.2 Deed-No.161/2010 Notarial Deed recorded in Frankfurt am Main, Germany this 28th day of May 2010, Today before me, the undersigned Notary Dr. Klaus Sommerlad, with offices in Frankfurt am Main, Germany, there appeared: a) Dr. Christoph Papenheim, born 28 March 1967, with business address c/o DLA Piper UK LLP, Westhafenplatz 1, 60327 Frankfurt am Main, identified by presenting his valid |
|
| November 7, 2011 |
Deed No. 134/2010 EXHIBIT 2.1 Recorded at Frankfurt am Main on this 29th day of April 2010, before me, the undersigned attorney-at-law Dr. Frank Schreiber as officially appointed representative of the Notary Dr. Klaus Sommerlad practicing in Frankfurt am Main appeared today: a) Dr. Christoph Papenheim, born 28 March 1967, with business address c/o DLA Piper UK LLP, Westhafenplatz 1, 60327 Frankfur |
|
| November 7, 2011 |
Exhibit 10.15 EXECUTION COPY $40,000,000 CREDIT AGREEMENT between ERESEARCHTECHNOLOGY, INC., as the Borrower, and CITIZENS BANK OF PENNSYLVANIA, as the Lender Dated as of May 27, 2010 TABLE OF CONTENTS Page SECTION 1. DEFINITIONS 1 1.1. Defined Terms 1 1.2. Other Definitional Provisions 21 SECTION 2. LOANS AND TERMS OF COMMITMENTS 22 2.1. The Loans 22 2.2. Notes 23 2.3. Procedure for Revolver Loan |
|
| November 7, 2011 |
Exhibit 10.16 REVOLVER NOTE U.S. $40,000,000 May 27, 2010 Philadelphia, Pennsylvania FOR VALUE RECEIVED, ERESEARCHTECHNOLOGY, INC., a Delaware corporation (the ?Borrower?), hereby unconditionally promises to pay to the order of CITIZENS BANK OF PENNSYLVANIA (the ?Lender?) at its office located at 3025 Chemical Road, Suite 300, Plymouth Meeting, PA 19462, on the Termination Date (as defined in the |
|
| November 7, 2011 |
Exhibit 10.17 EXECUTION COPY Guaranty Guaranty, dated as of May 27, 2010 (this ?Guaranty?), by ERT TECH CORPORATION, a Delaware corporation (?ERT Tech?), ERT INVESTMENT CORPORATION, a Delaware corporation (?ERT Investment?), COVANCE CARDIAC SAFETY SERVICES INC., a Pennsylvania corporation (?Covance?), each of the other entities that becomes a party hereto pursuant to Section 24 ( Additional Guaran |
|
| October 27, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2011 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commissio |
|
| October 27, 2011 |
Exhibit 99.1 ERT Reports Third Quarter 2011 Operating Results ? Record revenues of $48.1 million ? Diluted net income per share ? GAAP of $0.09 / Non-GAAP of $0.11 ? Record bookings of $78.4 million ? Record backlog of $343.8 million PHILADELPHIA, Oct. 27, 2011 /PRNewswire/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERT) a global technology-driven provider of services and customizable medical dev |
|
| October 18, 2011 |
Correspondence October 18, 2011 VIA EDGAR Securities and Exchange Commission 100 F Street, N. |
|
| September 8, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5)* ERESEARCH TECHNOLOGY INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) August 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is fi |
|
| September 8, 2011 |
EXHIBIT 99.1 ? JOINT FILING AGREEMENT Exhibit 99.1 EXHIBIT 99.1 ? JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the complete |
|
| August 22, 2011 |
Correspondence August 22, 2011 Securities and Exchange Commission 100 F Street, N. |
|
| August 8, 2011 |
As filed with the Securities and Exchange Commission on August 8, 2011 As filed with the Securities and Exchange Commission on August 8, 2011 Registration No. |
|
| August 5, 2011 |
Exhibit 10.44 MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into between Jeffrey S. Litwin (hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 1818 Market Street, Philadelphia PA 19103. 1. DUTIES AND RESPONSIBI |
|
| August 5, 2011 |
Exhibit 10.31 eResearchTechnology, Inc. Amended and Restated 2003 Equity Incentive Plan 1. Purpose The purpose of the Amended and Restated 2003 Equity Incentive Plan (referred to herein as the ?Plan?) of eResearchTechnology, Inc. (the ?Company?) is to provide a means by which certain employees and directors of, and others providing services to or having a relationship with, the Company and its sub |
|
| August 5, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) þ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2011 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file number: |
|
| August 1, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2011 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission F |
|
| August 1, 2011 |
Exhibit 99.1 ERT Reports Second Quarter 2011 Operating Results ? Revenues of $42.8 million ? GAAP diluted net income per share of $0.04 / Non-GAAP diluted net income per share of $0.06 ? Bookings of $70.9 million ? Backlog of $333.2 million PHILADELPHIA, August 1, 2011 /PRNewswire-First Call/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERT ? News) a global technology-driven provider of services an |
|
| August 1, 2011 |
Amended and Restated Bylaws eResearchTechnology, Inc. (as amended through July 27, 2011) Exhibit 3.1 Amended and Restated Bylaws of eResearchTechnology, Inc. (as amended through July 27, 2011) Table of Contents Page No. ARTICLE I CORPORATE OFFICES 1 Section 1.1 Registered Office 1 Section 1.2 Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 Section 2.1 Place of Meetings 1 Section 2.2 Annual Meeting 1 Section 2.3 Special Meetings 1 Section 2.4 Advance Notice Procedures for Busines |
|
| May 6, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2011 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file number: |
|
| May 6, 2011 |
Exhibit 10.49 Amendment No. 1 to Management Employment Agreement This Amendment No. 1 to Management Employment Agreement (the ?Amendment?) is hereby entered into between Thomas P. Devine (hereinafter known as the ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?). Background The Employee and the Company are parties to a Manageme |
|
| May 6, 2011 |
Exhibit 10.48 MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into between Thomas Devine (hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 30 S. 17th Street, Philadelphia, PA 19103. 1. DUTIES AND RESPONSIBILITI |
|
| May 2, 2011 |
Exhibit 99.1 ERT Reports First Quarter 2011 Operating Results ? Revenues of $41.7 million ? GAAP diluted net income per share of $0.06 / Non-GAAP diluted net income per share of $0.09 ? Bookings of $71.8 million PHILADELPHIA, May 2, 2011 /PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERT - News) a global technology-driven provider of services and customizable medical devices to |
|
| May 2, 2011 |
Exhibit 99.2 News Release Media Contacts: Keith Schneck Robert East eResearchTechnology, Inc. Westwicke Partners, LLC 215-282-5566 443-213-0502 ERT Announces Appointment of New President and CEO PHILADELPHIA, May 2, 2011 /PRNewswire-First Call/ eResearchTechnology, Inc. (ERT), (Nasdaq: ERT ? News) a global technology-driven provider of services and customizable medical devices to bio-pharmaceutica |
|
| May 2, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2011 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission |
|
| April 22, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2011 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission |
|
| April 22, 2011 |
Exhibit 99.1 FIRM and AFFlLIATE OFFICES NEW YORK LONDON SINGAPORE LOS ANGELES CHICAGO HOUSTON HANOI PHILADELPHIA SAN DIEGO SAN FRANCISCO BALTIMORE BOSTON WASHINGTON, DC LAS VEGAS ATLANTA MIAMI PITTSBURGH NEWARK BOCA RATON WILMINGTON CHERRY HILL PRINCETON LAKE TAHOE HO CHI MINH CITY SHELDON M. BONOVITZ DIRECT DIAL: 215.979.1972 PERSONAL FAX: 215.689.3546 E-MAIL: [email protected] www.duane |
|
| March 9, 2011 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| March 3, 2011 |
EX-10.59 2 w81789exv10w59.htm EX-10.59 EXHIBIT 10.59 RETIREMENT AGREEMENT This Retirement Agreement dated December 21, 2010 is made by and between eResearchTechnology, Inc., a Delaware corporation (“ERT”) and Michael J. McKelvey, an individual residing in Arlington, Virginia (“Executive”). Background ERT and Executive are parties to a Management Employment Agreement dated June 23, 2006, as amended |
|
| March 3, 2011 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name Jurisdiction of Organization ERT Services, Inc. Delaware eRT Investment Corporation Delaware eRT Tech Corporation Delaware Covance Cardiac Safety Services Inc. Pennsylvania eResearchTechnology Limited United Kingdom eResearchTechnology UK 1 Limited United Kingdom eResearchTechnology UK 2 Limited United Kingdom eResearchTechnology GmbH Germany Biosigna G |
|
| March 3, 2011 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2010 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-29100 eResearchTech |
|
| March 3, 2011 |
exv12w1 Exhibit 12.1 eResearchTechnology, Inc. Statement of Computation of Ratio of Earnings to Fixed Charges The following table sets forth our ratio of earnings to fixed charges for the period indicated: Year Ended December 31, 2006 2007 2008 2009 2010 (dollars in thousands) Income before income taxes $ 13,215 $ 24,457 $ 40,125 $ 17,478 $ 14,422 Fixed charges: Interest expense $ 10 $ 106 $ 28 $ |
|
| March 1, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2011 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commissi |
|
| March 1, 2011 |
Exhibit 99.1 ERT Reports Fourth Quarter and Full Year 2010 Operating Results ? Revenues of $44.9 million for the fourth quarter and $141.0 million for 2010 ? GAAP diluted net income per share of $0.08 for the fourth quarter / Non-GAAP diluted net income per share of $0.12 for the fourth quarter ? Bookings of $58.9 million for the fourth quarter ? 2011 guidance for revenue of $178 to $188 million / |
|
| February 10, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* ERESEARCH TECHNOLOGY INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is |
|
| February 10, 2011 |
EXHIBIT 99.1 ? JOINT FILING AGREEMENT Exhibit 99.1 EXHIBIT 99.1 ? JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the complete |
|
| January 28, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* eResearch Technology, Inc. (Name of Issuer) Common Stocks (Title of Class of Securities) 29481V108 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi |
|
| January 4, 2011 |
EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Date of Earliest Transaction Required to be Reported: December 31, 2010 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable i |
|
| December 21, 2010 |
ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO Exhibit 99.1 Media Contacts: Fiona Robinson The Scott Partnership Tel: +44 1477 539539 [email protected] News Release John Blakeley ERT +1 215 972 0420 [email protected] ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO PHILADELPHIA, PA, 21 December 2010/PRNewswire-FirstCall/ ? ERT (Nasdaq: ERES - News), a global provider of technology and services to the pharmaceutical, biotechnol |
|
| December 21, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Commissi |
|
| December 10, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Commissio |
|
| November 30, 2010 |
Table of Contents As filed pursuant to Rule 424(b)(3) Registration Statement No. 333-170526 PROSPECTUS eResearchTechnology, Inc. $150,000,000 Debt Securities Common Stock Preferred Stock Depositary Shares Warrants Units We may offer from time to time to sell debt securities, common stock, preferred stock, depositary shares, warrants and units that include any of these securities. The debt securiti |
|
| November 10, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Commissi |
|
| November 10, 2010 |
eResearchTechnology, Inc. Statement of Computation of Ratio of Earnings to Fixed Charges exv12w1 Exhibit 12.1 eResearchTechnology, Inc. Statement of Computation of Ratio of Earnings to Fixed Charges The following table sets forth our ratio of earnings to fixed charges for the period indicated: Nine Months Ended Year Ended December 31, Sept. 30, 2005 2006 2007 2008 2009 2010 (dollars in thousands) Income before income taxes: $ 24,372 $ 13,215 $ 24,457 $ 40,125 $ 17,478 $ 8,939 Fixed ch |
|
| November 10, 2010 |
ERESEARCHTECHNOLOGY, INC. Dated as of EXHIBIT 4.1 ERESEARCHTECHNOLOGY, INC. Company INDENTURE Dated as of Trustee CROSS-REFERENCE TABLE* Trust Indenture Act Section Indenture Section 310(a)(1) 7.10 (a)(2) 7.10 (a)(3) N.A. (a)(4) N.A. (a)(5) 7.10 (b) 7.10 (c) N.A. 311(a) 7.11 (b) 7.11 (c) N.A. 312(a) 2.05 (b) 12.03 (c) 12.03 313(a) 7.06 (b) 7.06 (c) 7.06; 12.02 (d) 7.06 314(a) 4.03; 12.02; 12.05 (c)(1) 12.04 (c)(2) 12.04 (c)(3) N.A. (e |
|
| November 10, 2010 |
As filed with the Securities and Exchange Commission on November 10, 2010 S-3 1 w80421sv3.htm FORM S-3 Table of Contents As filed with the Securities and Exchange Commission on November 10, 2010 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 22-3264604 (State or other jur |
|
| November 10, 2010 |
ERT FILES SHELF REGISTRATION STATEMENT Exhibit 99.1 Contact: Keith Schneck Robert East eResearchTechnology, Inc. Westwicke Partners, LLC 215-282-5566 410-321-9652 ERT FILES SHELF REGISTRATION STATEMENT PHILADELPHIA November 10, 2010/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERES - News), a global provider of technology and services to the pharmaceutical, biotechnology, and medical device industries, today announ |
|
| November 9, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2010 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file num |
|
| November 4, 2010 |
Exhibit 99.1 ERT Reports Third Quarter 2010 Results ? Revenues of $45.1 million for the third quarter ? up 99% from prior year ? GAAP diluted net income per share of $0.06 for the third quarter / Non-GAAP diluted net income per share of $0.11 for the third quarter ? Bookings of $59.1 million for the third quarter PHILADELPHIA, November 4, 2010/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT |
|
| November 4, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commissio |
|
| September 16, 2010 |
ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer Exhibit 99.1 ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer PHILADELPHIA, September 10, 2010/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERES - News), a global provider of technology and services to the pharmaceutical, biotechnology, and medical device industries, today announced that Michael McKelvey will be retiring from his positions as Pr |
|
| September 16, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 10, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Commiss |
|
| August 9, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) þ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2010 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file number: |
|
| August 9, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Commission |
|
| August 9, 2010 |
Exhibit 99.1 ERT Reports Second Quarter 2010 Results ? Revenues of $29.1 million for second quarter ? GAAP diluted net income per share of $0.02 for second quarter / Non-GAAP diluted net income per share of $0.08 for second quarter ? Bookings of $51.0 million ? Backlog reaches $299.4 million ? 2010 guidance for GAAP diluted net income per share of $0.16 to $0.21 / Non-GAAP diluted net income per s |
|
| August 5, 2010 |
Exhibit 99.1 CareFusion Germany 234 GmbH H?chberg Carve Out Financial Statements of Research Services Division of CareFusion Germany 234 GmbH for the years ended December 31, 2008 and 2009 Ernst & Young GmbH Wirtschaftspr?fungsgesellschaft Report of Independent Auditors The Management Board of CareFusion Germany 234 We have audited the accompanying combined balance sheets of Research Services (com |
|
| August 5, 2010 |
Form 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2010 (May 27, 2010) eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or oth |
|
| August 5, 2010 |
Exhibit 99.2 RESEARCH SERVICES (A DIVISION OF CAREFUSION CORPORATION) CONDENSED COMBINED STATEMENTS OF OPERATIONS (unaudited) Three Three Months Ended Months Ended (in thousands) March 31, 2010 March 31, 2009 Product Revenue $ 6,630 $ 2,623 Service Revenue 9,769 4,246 Total Revenue 16,399 6,869 Cost of Products and Services Sold 8,095 4,272 Gross Margin 8,304 2,597 Selling, General and Administrat |
|
| August 5, 2010 |
Exhibit 99.3 eResearchTechnology, Inc and Subsidiaries Unaudited Pro Forma Condensed Combined Financial Information The accompanying unaudited pro forma condensed combined financial statements present the historical financial information of eResearchTechnology, Inc. (?ERT? or the ?Company?) as adjusted for the purchase of Research Services Germany 234 GmbH (?RS?), which was formed as a result of a |
|
| June 3, 2010 |
EX-10.1 2 c02037exv10w1.htm EXHIBIT 10.1 Exhibit 10.1 EXECUTION COPY $40,000,000 CREDIT AGREEMENT between ERESEARCHTECHNOLOGY, INC., as the Borrower, and CITIZENS BANK OF PENNSYLVANIA, as the Lender Dated as of May 27, 2010 TABLE OF CONTENTS Page SECTION 1. DEFINITIONS 1 1.1. Defined Terms 1 1.2. Other Definitional Provisions 21 SECTION 2. LOANS AND TERMS OF COMMITMENTS 22 2.1. The Loans 22 2.2. N |
|
| June 3, 2010 |
ERT Closes the Acquisition of the Research Services Division of CareFusion Corporation Exhibit 99.1 ERT Closes the Acquisition of the Research Services Division of CareFusion Corporation PHILADELPHIA, June 1, 2010/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERES ? News), a global provider of technology and services to the pharmaceutical, biotechnology, and medical device industries, announced the successful closing of the acquisition of the Research Services Di |
|
| June 3, 2010 |
Exhibit 10.3 EXECUTION COPY Guaranty Guaranty, dated as of May 27, 2010 (this ?Guaranty?), by ERT TECH CORPORATION, a Delaware corporation (?ERT Tech?), ERT INVESTMENT CORPORATION, a Delaware corporation (?ERT Investment?), COVANCE CARDIAC SAFETY SERVICES INC., a Pennsylvania corporation (?Covance?), each of the other entities that becomes a party hereto pursuant to Section 24 ( Additional Guarant |
|
| June 3, 2010 |
Exhibit 10.5 Deed-No.161/2010 Notarial Deed recorded in Frankfurt am Main, Germany this 28th day of May 2010, Today before me, the undersigned Notary Dr. Klaus Sommerlad, with offices in Frankfurt am Main, Germany, there appeared: a) Dr. Christoph Papenheim, born 28 March 1967, with business address c/o DLA Piper UK LLP, Westhafenplatz 1, 60327 Frankfurt am Main, identified by presenting his valid |
|
| June 3, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission Fi |
|
| June 3, 2010 |
Exhibit 10.4 EXECUTION COPY DATED MAY 27, 2010 (1) ERESEARCHTECHNOLOGY, INC as Chargor (2) CITIZENS BANK OF PENNSYLVANIA as Chargee CHARGE OVER SHARES AND SECURITIES 160 Queen Victoria Street London EC4V 4QQ, UK Tel: +44 (0) 20 7184 7000 Fax: +44 (0) 20 7184 7001 1. DEFINITIONS, CONSTRUCTION AND THIRD PARTY RIGHTS 2 2. COVENANT TO PAY 5 3. FIXED SECURITY 5 4. FURTHER ASSURANCE 5 5. REPRESENTATIONS |
|
| June 3, 2010 |
REVOLVER NOTE U.S. $40,000,000 May 27, 2010 Philadelphia, Pennsylvania Exhibit 10.2 REVOLVER NOTE U.S. $40,000,000 May 27, 2010 Philadelphia, Pennsylvania FOR VALUE RECEIVED, ERESEARCHTECHNOLOGY, INC., a Delaware corporation (the ?Borrower?), hereby unconditionally promises to pay to the order of CITIZENS BANK OF PENNSYLVANIA (the ?Lender?) at its office located at 3025 Chemical Road, Suite 300, Plymouth Meeting, PA 19462, on the Termination Date (as defined in the C |
|
| May 12, 2010 |
EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Date of Earliest Transaction Required to be Reported: May 10, 2010 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquir |
|
| May 7, 2010 |
EXHIBIT 10.10 RECIPROCAL GUARANTY THIS RECIPROCAL GUARANTY (this ?Guaranty?), dated as of April 29, 2010, is executed by CareFusion Corporation, a Delaware corporation (the ?Seller Guarantor?), in favor of Blitz F10-acht-drei-f?nf GmbH & Co. KG, a limited partnership organized under the laws of the Federal Republic of Germany (?Purchaser?), and by eResearchTechnology, Inc., a Delaware corporation |
|
| May 7, 2010 |
Deed No. 134/2010 EXHIBIT 10.9 Recorded at Frankfurt am Main on this 29th day of April 2010, before me, the undersigned attorney-at-law Dr. Frank Schreiber as officially appointed representative of the Notary Dr. Klaus Sommerlad practicing in Frankfurt am Main appeared today: a) Dr. Christoph Papenheim, born 28 March 1967, with business address c/o DLA Piper UK LLP, Westhafenplatz 1, 60327 Frankfu |
|
| May 7, 2010 |
Exhibit 10.13 eResearchTechnology, Inc. 2010 Bonus Plan Set forth below is a summary of the eResearchTechnology, Inc. (?ERT? or the ?Company?) 2010 Bonus Plan (the ?2010 Plan?) approved by the Compensation Committee and ratified by the Board of Directors at their respective meetings on February 23, 2010, to be effective for fiscal 2010. The purpose of the 2010 Plan is to promote the interests of t |
|
| May 7, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2010 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file number: |
|
| May 7, 2010 |
Exhibit 10.46 eResearchTechnology, Inc. CONSULTANT AGREEMENT This Consultant Agreement (the “Agreement”) is hereby entered into effective the 1st day of March, 2010 by and between Joel Morganroth, M.D., P.C. (hereinafter known as “Consultant”) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the “Company”), and having its principal offices at 1818 Marke |
|
| May 7, 2010 |
Exhibit 10.42 eResearchTechnology, Inc AMENDED AND RESTATED MANAGEMENT EMPLOYMENT AGREEMENT This Amended and Restated Management Employment Agreement (the “Agreement”) is hereby entered into effective March 1, 2010 between Joel Morganroth (hereinafter known as “Employee”) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the “Company”) and having its pri |
|
| May 7, 2010 |
EXHIBIT 10.56 Amendment No. 1 to Management Employment Agreement This Amendment No. 1 to Management Employment Agreement (the ?Amendment?) is hereby entered into between Keith D. Schneck (hereinafter known as the ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?). Background The Employee and the Company are parties to a Manageme |
|
| May 7, 2010 |
Exhibit 10.51 Amendment No. 1 to Management Employment Agreement This Amendment No. 1 to Management Employment Agreement (the ?Amendment?) is hereby entered into between Amy Furlong (hereinafter known as the ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?). Background The Employee and the Company are parties to a Management Em |
|
| May 7, 2010 |
Exhibit 10.50 Amendment No. 1 to Management Employment Agreement This Amendment No. 1 to Management Employment Agreement (the ?Amendment?) is hereby entered into between Jeffrey S. Litwin (hereinafter known as the ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?). Background The Employee and the Company are parties to a Managem |
|
| May 7, 2010 |
Exhibit 10.49 Amendment No. 1 to Management Employment Agreement This Amendment No. 1 to Management Employment Agreement (the ?Amendment?) is hereby entered into between Michael McKelvey (hereinafter known as the ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?). Background The Employee and the Company are parties to a Manageme |
|
| April 30, 2010 |
ERT Agrees to Acquire the Research Services Division of CareFusion Exhibit 99.1 ERT Agrees to Acquire the Research Services Division of CareFusion ? Adds market leadership in the respiratory core lab market to ERT?s existing market leading position in the cardiac safety core lab market ? Expands our high quality service and technology offerings to our pharmaceutical customers worldwide ? Establishes a global platform for growth with broad presence in the US and E |
|
| April 30, 2010 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Co |
|
| April 30, 2010 |
ERT First Quarter 2010 Earnings Results Conference Call April 29, 2010 Exhibit 99.2 ERT First Quarter 2010 Earnings Results Conference Call April 29, 2010 Good afternoon. Thank you for joining us for ERT?s first quarter 2010 earnings results conference call. A press release announcing the first quarter results was released this afternoon and is available at ERT.com and most financial websites. We also issued a press release this afternoon announcing the signing of a |
|
| April 29, 2010 |
Exhibit 99.1 ERT Reports First Quarter 2010 Results Conference Call to Discuss Acquisition and First Quarter Results of Operations to be held on April 29, 2010 at 5:00 PM EDT PHILADELPHIA, April 29, 2010/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERES ? News), a global provider of technology and services to the pharmaceutical, biotechnology, and medical device industries, an |
|
| April 29, 2010 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Co |
|
| March 19, 2010 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Co |
|
| March 9, 2010 |
EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Date of Earliest Transaction Required to be Reported: March 5, 2010 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inqui |
|
| March 5, 2010 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| March 3, 2010 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2009 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-29100 eResearchTech |
|
| March 3, 2010 |
MANAGEMENT EMPLOYMENT AGREEMENT Exhibit 10.55 MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into between John Sory (hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 1818 Market Street, Philadelphia PA 19103. 1. DUTIES AND RESPONSIBILITIES E |
|
| March 1, 2010 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) |
|
| February 25, 2010 |
ERT Reports Fourth Quarter and Full Year 2009 Results Exhibit 99.1 ERT Reports Fourth Quarter and Full Year 2009 Results PHILADELPHIA, February 25, 2010/PRNewswire-FirstCall/ — eResearchTechnology, Inc. (ERT), (Nasdaq: ERES — News), a leading provider of centralized ECG, ePRO, and other services to the bio/pharmaceutical, medical device and related industries, announced today results for the fourth quarter and twelve-month period ended December 31, 2 |
|
| February 25, 2010 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) |
|
| February 9, 2010 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* eresearch technology Inc (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is |
|
| January 5, 2010 |
EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Date of Earliest Transaction Required to be Reported: December 31, 2009 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable i |
|
| November 9, 2009 |
EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Statement for Month/Day/Year: November 5, 2009 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry and to the best of |
|
| November 6, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2009 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file num |
|
| November 6, 2009 |
Exhibit 10.31 eResearchTechnology, Inc. Amended and Restated 2003 Equity Incentive Plan 1. Purpose The purpose of the Amended and Restated 2003 Equity Incentive Plan (referred to herein as the ?Plan?) of eResearchTechnology, Inc. (the ?Company?) is to provide a means by which certain employees and directors of, and others providing services to or having a relationship with, the Company and its sub |
|
| November 4, 2009 |
EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Statement for Month/Day/Year: November 2, 2009 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry and to the best of |
|
| October 29, 2009 |
ERT Reports Third Quarter 2009 Results Exhibit 99.1 ERT Reports Third Quarter 2009 Results PHILADELPHIA, October 29, 2009/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERES - News), a leading provider of centralized ECG, ePRO and other services to the biopharmaceutical, medical device and related industries, announced today results for the third quarter and nine-month period ended September 30, 2009. Unless otherwis |
|
| October 29, 2009 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2009 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) ( |
|
| September 10, 2009 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* eresearch technology Inc (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) August 31, 2009 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is fi |
|
| August 7, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2009 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to . Commission file number |
|
| August 7, 2009 |
Exhibit 10.28 MODIFICATION NUMBER ONE TO PROMISSORY NOTE AND LOAN AGREEMENT eResearchtechnology, Inc. a/k/a eResearch Technology, Inc. 1818 Market Street, Suite 1000 Philadelphia, Pennsylvania 19103-3638 eRT Investment Corporation 1105 N. Market Street, Suite 1300 Wilmington, Delaware 19801 eRT Tech Corporation 1105 N. Market Street, Suite 1300 Wilmington, Delaware 19801 (Individually and collecti |
|
| July 30, 2009 |
ERT Reports Second Quarter 2009 Results Exhibit 99.1 ERT Reports Second Quarter 2009 Results PHILADELPHIA, July 30, 2009/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERES - - News), a leading provider of centralized ECG, ePRO and other services to the biopharmaceutical, medical device and related industries, announced today results for the second quarter and six-month period ended June 30, 2009. Unless otherwise not |
|
| July 30, 2009 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2009 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Com |
|
| July 6, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* OMNICOMM SYSTEMS, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 68212 U 10 4 (CUSIP Number) Keith D. Schneck ERESEARCHTECHNOLOGY, INC. 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 (Name, Address and Teleph |
|
| July 6, 2009 |
LOCK-UP AND REGISTRATION RIGHTS AGREEMENT Exhibit 1 Exhibit 1 LOCK-UP AND REGISTRATION RIGHTS AGREEMENT THIS LOCK-UP AND REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made and entered into as of June 23, 2009 (the “Effective Date”), by and between eRESEARCHTECHNOLOGY, INC. |
|
| July 6, 2009 |
EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Date of Earliest Transaction Required to be Reported: July 1, 2009 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquir |
|
| June 23, 2009 |
e8vk Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| June 23, 2009 |
Exhibit 99.1 OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology ? Acquisition Extends the Company?s Suite of Products and Increases Breadth of EDC Customers ? June 23, 2009 FORT LAUDERDALE, FL & PHILADELPHIA, PA. ? (PRNewswire) ? OmniComm Systems, Inc.? (OTC BB:OMCM ? News) (?OmniComm?), a leader in integrated electronic data capture (EDC) solutions for clinical trials, |
|
| May 8, 2009 |
Exhibit 10.32 FIRST AMENDMENT TO THE eResearchTechnology, Inc. AMENDED AND RESTATED 2003 EQUITY INCENTIVE PLAN WHEREAS, eResearchTechnology, Inc. (the “Company”) has adopted the eResearch Technology, Inc. Amended and Restated 2003 Equity Incentive Plan (the “Plan”) for the benefit of certain of its employees and directors; and WHEREAS, the Company has reserved the right to amend the Plan at any ti |
|
| May 8, 2009 |
Exhibit 10.57 eResearchTechnology, Inc. MANAGEMENT EMPLOYMENT AGREEMENT The following agreement is hereby entered into between Joel Morganroth (hereinafter known as Employee) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 1818 Market Street, Philadelphia, PA 19103. 1. DUTIES AND RESPONSIBILITIES Emplo |
|
| May 8, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 c84874e10vq.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) þ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2009 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional perio |
|
| May 8, 2009 |
Exhibit 10.14 eResearchTechnology, Inc. 2009 Bonus Plan Set forth below is a summary of the eResearchTechnology, Inc. (?ERT? or the ?Company?) 2009 Bonus Plan (the ?2009 Plan?) recommended by the Compensation Committee and approved by the Board of Directors at meetings on February 24 and 26, 2009, to be effective for fiscal 2009. The purpose of the 2009 Plan is to promote the interests of the Comp |
|
| May 8, 2009 |
Exhibit 10.58 eResearchTechnology, Inc. CONSULTANT AGREEMENT The following agreement is hereby entered into between, Joel Morganroth, M.D., P.C. (hereinafter known as Consultant) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the “Company”), and having its principal offices at 1818 Market Street, Philadelphia, PA 19103 1. SCOPE OF PROJECT a) Consultan |
|
| May 8, 2009 |
Exhibit 10.45 MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into between Amy Furlong (hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 30 S. 17th Street, Philadelphia, PA 19103. 1. DUTIES AND RESPONSIBILITIES |
|
| May 5, 2009 |
EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Date of Earliest Transaction Required to be Reported: May 1, 2009 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry |
|
| April 30, 2009 |
ERT Reports First Quarter 2009 Results EX-99.1 2 w73847exv99w1.htm EXHIBIT 99.1 Exhibit 99.1 ERT Reports First Quarter 2009 Results PHILADELPHIA, April 30, 2009/PRNewswire-FirstCall/ — eResearchTechnology, Inc. (ERT), (Nasdaq: ERES — News), a leading provider of centralized ECG, eClinical technology, ePRO and other services to the biopharmaceutical, medical device, and related industries, announced today results for the first quarter o |
|
| April 30, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 30, 2009 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission |
|
| March 13, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| March 2, 2009 |
8-K 1 c81920e8vk.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2009 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdicti |
|
| March 2, 2009 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2008 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-29100 eResearchTechnology, Inc. ( |
|
| March 2, 2009 |
MANAGEMENT EMPLOYMENT AGREEMENT Exhibit 10.53 MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into between Keith D. Schneck hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 30 S. 17th Street, Philadelphia, PA 19103. 1. DUTIES AND RESPONSIBILI |
|
| February 26, 2009 |
ERT Reports Fourth Quarter and Full Year 2008 Results Filed by Bowne Pure Compliance Exhibit 99.1 ERT Reports Fourth Quarter and Full Year 2008 Results Q4 2008 Net Revenues — $30.1 million vs. $28.9 million in Q4 2007 — a 4.0% increase Q4 2008 Diluted Net Income per Share — $0.11 vs. $0.10 in Q4 2007 — a 10.0% increase Q4 2008 New Bookings of $45.1 million vs. $39.2 million in Q4 2007 — a 15.1% increase 2008 Net Revenues — $133.1 million vs. $98.7 mi |
|
| February 26, 2009 |
Filed by Bowne Pure Compliance UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 10, 2009 |
OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response. |
|
| February 6, 2009 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* eresearchtechnology Inc (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) December 31, 2008 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is f |
|
| January 5, 2009 |
EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Date of Earliest Transaction Required to be Reported: January 2, 2009 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inq |
|
| December 24, 2008 |
Sincerely, /s/ Keith D. Schneck Executive Vice President, Chief Financial Officer and Secretary December 24, 2008 via Edgar Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7010 Re: eResearchTechnology, Inc. Form 10-K for fiscal year ended December 31, 2007 Filed March 7, 2008 File No. 000-29100 Ladies and Gentlemen: Set forth below is the comment contained in your December 10, 2008 letter with respect to the above-captioned filing, together with our response to t |
|
| November 24, 2008 |
corresp November 24, 2008 via Edgar Securities and Exchange Commission 100 F Street, N. |
|
| November 19, 2008 |
corresp November 19, 2008 via Edgar Securities and Exchange Commission 100 F Street, N. |
|
| November 7, 2008 |
Exhibit 10.20 1818 MARKET STREET OFFICE LEASE BETWEEN NNN 1818 Market Street, LLC, NNN 1818 Market Street 1, LLC, NNN 1818 Market Street 2, LLC, NNN 1818 Market Street 3, LLC, NNN 1818 Market Street 4, LLC, NNN 1818 Market Street 5, LLC, NNN 1818 Market Street 6, LLC, NNN 1818 Market Street 7, LLC, NNN 1818 Market Street 8, LLC, NNN 1818 Market Street 9, LLC, NNN 1818 Market Street 10, LLC, NNN 18 |
|
| November 7, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2008 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file num |
|
| November 7, 2008 |
EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Statement for Month/Day/Year: November 7, 2008 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry and to the best of |
|
| October 30, 2008 |
eResearchTechnology Reports Third Quarter 2008 Results Q3 2008 Net Revenues — $33. |
|
| October 30, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: October 30, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction (Commission (I.R.S. Employer |
|
| September 9, 2008 |
EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Statement for Month/Day/Year: September 5, 2008 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry and to the best o |
|
| August 22, 2008 |
EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Statement for Month/Day/Year: March 10, 2008 Issuer & Symbol: Electronics for Imaging, Inc. (EFII) Address of each Reporting Person for this Form 3: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry and to the best o |
|
| August 14, 2008 |
EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Statement for Month/Day/Year: August 12, 2008 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry and to the best of |
|
| August 7, 2008 |
EXHIBIT 10.51 AMENDED AND RESTATED MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into on June 17, 2008 between Steven M. Eisenstein (hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?), a Delaware corporation having its principal offices at 30 S. |
|
| August 7, 2008 |
EXHIBIT 10.30 PROMISSORY NOTE $3,000,000.00 June26, 2008 eResearch Technology, Inc. 30 South 17th Street 8th Floor Philadelphia, Pennsylvania 19103 eRT Investment Corporation 3411 Silverside Road 103 Springer Building Wilmington, Delaware 19810 eRT Tech Corporation 3411 Silverside Road 103 Springer Building Wilmington, Delaware 19810 (Individually and collectively, ?Borrower?) Wachovia Bank, Natio |
|
| August 7, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2008 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file number 0 |
|
| August 7, 2008 |
EXHIBIT 10.29 LOAN AGREEMENT Wachovia Bank, National Association Philadelphia, Pennsylvania 19109 (Hereinafter referred to as the ?Bank?) eResearch Technology, Inc. 30 South 17th Street 8th Floor Philadelphia, Pennsylvania 19103 eRT Investment Corporation 3411 Silverside Road 103 Springer Building Wilmington, Delaware 19810 eRT Tech Corporation 3411 Silverside Road 103 Springer Building Wilmington |
|
| August 4, 2008 |
Exhibit 99.1 eResearchTechnology Reports Second Quarter 2008 Results Q2 2008 Net Revenues ? a record $35.5 million vs. $24.7 million in Q2 2007 ? an increase of 43.4% Q2 2008 Diluted Net Income per Share ? $0.13 vs. $0.08 in Q2 2007 ? an increase of 62.5% Q2 2008 Operating Income margin of 30.3% vs. 25.3% in Q2 2007 Q2 2008 New Bookings of $49.0 million vs. $34.5 million in Q2 2007 PHILADELPHIA, A |
|
| August 4, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 30, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission F |
|
| July 23, 2008 |
e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 23, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commiss |
|
| July 23, 2008 |
exv99w1 Exhibit 99.1 eResearchTechnology Names New Chief Financial Officer PHILADELPHIA, July 23/PRNewswire-FirstCall/ — eResearchTechnology, Inc. (eRT or the Company), (Nasdaq: ERES - News), a leading provider of centralized ECG and eClinical technology, ePRO and other services to the pharmaceutical, biotechnology, medical device and related industries, announced today the appointment of Mr. Keit |
|
| July 18, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 14, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission F |
|
| June 18, 2008 |
8-K 1 w61289e8vk.htm FORM 8-K ERESEARCHTECHNOLOGY, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: June 17, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (Sta |
|
| May 20, 2008 |
Exhibit 99.1 eResearchTechnology Announces Resignation of its CFO PHILADELPHIA, May 20/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (eRT), (Nasdaq: ERES - News), a leading provider of centralized ECG and eClinical technology, ePRO and other services to the pharmaceutical, biotechnology, medical device and related industries, announced today that Richard Baron has informed the company that he |
|
| May 20, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 20, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission Fi |
|
| May 8, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) þ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2008 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file number |
|
| May 8, 2008 |
Management Employment Agreement EXHIBIT 10.47 MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into between Robert Brown (hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 30 S. 17th Street, Philadelphia, PA 19103. 1. DUTIES AND RESPONSIBILITIE |
|
| May 8, 2008 |
Exhibit 10.13 eResearchTechnology, Inc. 2008 Bonus Plan Set forth below is a summary of the 2008 Bonus Plan recommended by the Compensation Committee and approved by the Board of Directors on February 19, 2008, to be effective for fiscal 2008. The purpose of the plan is to promote the interests of the Company and its stockholders by providing employees with financial rewards upon achievement of sp |
|
| May 5, 2008 |
e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 5, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commissio |
|
| May 5, 2008 |
exv99w1 eResearchTechnology Reports First Quarter 2008 Results Q1 2008 Net Revenues — $33. |
|
| March 11, 2008 |
DEF 14A 1 w51050def14a.htm DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, f |
|
| March 7, 2008 |
Subsidiaries of the Registrant Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name Jurisdiction of Organization eResearchTechnology Limited United Kingdom eRT Investment Corporation Delaware eRT Tech Corporation Delaware Covance Cardiac Safety Services Inc. Pennsylvania |
|
| March 7, 2008 |
Management Employment Agreement - Joel Morganroth Exhibit 10.42 eResearchTechnology, Inc. MANAGEMENT EMPLOYMENT AGREEMENT The following agreement is hereby entered into between Joel Morganroth (hereinafter known as Employee) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 30 S. 17th Street, Philadelphia, PA 19103. 1. DUTIES AND RESPONSIBILITIES Employ |
|
| March 7, 2008 |
Management Employment Agreement - George Tiger Exhibit 10.45 eResearchTechnology, Inc. MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into between George Tiger (hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 30 S. 17th Street, Philadelphia, PA 19103. 1. |
|
| March 7, 2008 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2007 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-29100 eResearchTechnology, Inc. ( |
|
| March 7, 2008 |
Consultant Agreement - Joel Morganroth Exhibit 10.46 eResearchTechnology, Inc. CONSULTANT AGREEMENT The following agreement is hereby entered into between, Joel Morganroth, M.D., P.C. (hereinafter known as Consultant) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the “Company”), and having its principal offices at 30 S. 17th Street, Philadelphia, PA 19103 1. SCOPE OF PROJECT a) Consultant |
|
| February 27, 2008 |
e8vkza UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 26, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of i |
|
| February 27, 2008 |
CORRECTION — eResearchTechnology, Inc, Exhibit 99.1 CORRECTION ? eResearchTechnology, Inc, PHILADELPHIA, February 27, 2008/PRNewswire-FirstCall/ ? In the news release, eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results, issued yesterday, February 26, by eResearchTechnology, Inc. over PR Newswire, we are advised by the company that in the ?Conference Call? section, the United States phone number to listen to the confe |
|
| February 26, 2008 |
Exhibit 99.1 eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results Q4 2007 Net Revenues ? $28.9 million vs. $19.9 million in Q4 2006 ? a 45% increase Q4 2007 Diluted Net Income per Share ? $0.10 vs. $0.04 in Q4 2006 Q4 2007 New Bookings Increase to $39.2 million PHILADELPHIA, February 26, 2008/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (eRT), (Nasdaq: ERES - News), a leading |
|
| February 26, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 26, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commissi |
|
| February 25, 2008 |
e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 19, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Com |
|
| February 11, 2008 |
Exhibit 99.2 COVANCE CARDIAC SAFETY SERVICES, INC. BALANCE SHEETS AS OF SEPTEMBER 30, 2007 AND DECEMBER 31, 2006 September 30, December 31, 2007 2006 (Dollars in thousands) (Unaudited) Assets Current Assets: Cash and cash equivalents $ ? $ ? Accounts receivable, net 5,352 5,172 Deferred income taxes 212 212 Prepaid expenses and other current assets 372 452 Total Current Assets 5,936 5,836 Property |
|
| February 11, 2008 |
Financial Statements For the Years Ended December 31, 2006 and 2005 and Nine Months Ended September 30, 2007 and 2006 Contents Exhibit 99. |
|
| February 11, 2008 |
e8vkza UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 to CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event February 11, 2008 reported): (November 28, 2007) eResearchTechnology, Inc. (Exact Name of Registrant Specified in Charter) Delaware 0-29100 22-3264604 (State or Other |
|
| February 11, 2008 |
EX-99.3 5 w48347exv99w3.htm THE UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET OF THE COMPANY AS OF SEPTEMBER 30, 2007 Exhibit 99.3 eResearchTechnology , Inc. and Subsidiaries Unaudited Pro Forma Condensed Combined Financial Information The accompanying unaudited pro forma condensed combined financial statements present the historical financial information of eResearchTechnology, Inc. (“ERT” |
|
| January 22, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.)* ERESEARCH TECHNOLOGY INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) December 31, 2007 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is fi |
|
| January 4, 2008 |
OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response. |
|
| January 3, 2008 |
EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Statement for Month/Day/Year: January 3, 2008 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry and to the best of |
|
| December 27, 2007 |
AGREEMENT JOINT FILING OF SCHEDULE 13D AND ALL FUTURE AMENDMENTS TO SCHEDULE 13D Exhibit 4 AGREEMENT JOINT FILING OF SCHEDULE 13D AND ALL FUTURE AMENDMENTS TO SCHEDULE 13D Each of the undersigned hereby agrees to file jointly the Statement on Schedule 13D to which this Agreement is attached, and any amendments to the Statement on Schedule 13D (the ?Schedule 13D?) with respect to Common Shares of eResearchTechnology, Inc. |
|
| December 27, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Act of 1934 (Amendment No. 1) * ERESEARCHTECHNOLOGY, INC. (Name of Issuer) Common Shares, $0.01 Par Value (Title of Class of Securities) 29481V108 (CUSIP Number) David K. Robbins, Esq. Bingham McCutchen LLP 355 South Grand Avenue, Suite 4400 Los Angeles, CA 90071 (213) 680-6400 (Name, Address |
|
| December 27, 2007 |
Schedule of Transactions Exhibit 3 Schedule of Transactions Shamrock Activist Value Fund, L. |
|
| December 4, 2007 |
Exhibit 2.1 SHARE PURCHASE AGREEMENT by and among ERESEARCHTECHNOLOGY, INC., COVANCE CENTRAL LABORATORY SERVICES LIMITED PARTNERSHIP, COVANCE CARDIAC SAFETY SERVICES INC. AND COVANCE INC. Dated as of November 27, 2007 TABLE OF CONTENTS ARTICLE 1 DEFINITIONS 2 1.1 Definitions 2 ARTICLE 2 THE TRANSACTION 2 2.1 Sale and Purchase of Shares 2 2.2 Purchase Price 2 2.3 Closing Time and Place 2 2.4 Delive |
|
| December 4, 2007 |
e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2007 (November 28, 2007) eResearchTechnology, Inc. (Exact Name of Registrant Specified in Charter) Delaware 0-29100 22-3264604 (State or Other Jurisdiction of Incorpo |
|
| December 4, 2007 |
Confidential Treatment Exhibit 10.1 PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE SECRETARY OF THE COMMISSION PURSUANT TO REGISTRANT?S APPLICATION OBJECTING TO DISCLOSURE AND REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 24b-2. THE OMITTED PORTIONS HAVE BEEN MARKED WITH BRACKETS. EXCLUSIVE MARKETING AGREEMENT This Exclusive Marketing Agreement (this ?Agreement?) is made t |
|
| November 28, 2007 |
Exhibit 99.1 Thursday November 27, 2007 Press Release SOURCE: eResearchTechnology, Inc. eResearchTechnology (eRT) Agrees to Acquire the Centralized ECG Business of Covance Covance and eRT Enter into Exclusive Marketing Agreement to Offer eRT?s Cardiac Safety Services to Covance?s Clients for 10 Years PHILADELPHIA, November 27, 2007 /PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (eRT), (Nasdaq: |
|
| November 28, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 27, 2007 eResearchTechnology, Inc. (Exact Name of Registrant Specified in Charter) Delaware 0-29100 22-3264604 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| November 9, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* eResearch Technology Inc. (Name of Issuer) Class A Common (Title of Class of Securities) 29481V108 (CUSIP Number) October 31, 2007 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th |
|
| November 5, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2007 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file num |
|
| November 1, 2007 |
exv99w1 Exhibit 99.1 eResearchTechnology Reports Third Quarter 2007 Results Net Income Increasing by 50% with EPS of $0.07 vs. $0.05 in Q3 2006 Q3 Revenues Increase to $24.0 Million and New Bookings Increase to $35.5 Million PHILADELPHIA, November 1, 2007/PRNewswire-FirstCall/ — eResearchTechnology, Inc. (eRT), (Nasdaq: ERES - News), a leading provider of centralized ECG, eClinical technology, ePR |
|
| November 1, 2007 |
e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: November 1, 2007 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Comm |
|
| August 10, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)* ERESEARCHTECHNOLOGY, INC. (Name of Issuer) Common Shares, $0.01 Par Value (Title of Class of Securities) 29481V108 (CUSIP Numb |
|
| August 10, 2007 |
AGREEMENT JOINT FILING OF SCHEDULE 13D AND ALL FUTURE AMENDMENTS TO SCHEDULE 13D Exhibit 2 AGREEMENT JOINT FILING OF SCHEDULE 13D AND ALL FUTURE AMENDMENTS TO SCHEDULE 13D Each of the undersigned hereby agrees to file jointly the Statement on Schedule 13D to which this Agreement is attached, and any amendments to the Statement on Schedule 13D (the ?Schedule 13D?) with respect to Common Shares of eResearchTechnology, Inc. |
|
| August 10, 2007 |
Exhibit 1 Schedule of Transactions Shamrock Activist Value Fund, L.P. Date Number of Common Shares Price Per Common Shares in $US* Total Purchase Price 06/11/07 32,861 $ 8.8678 $ 291,405 06/12/07 32,859 $ 8.7711 $ 288,210 06/13/07 32,876 $ 8.9009 $ 292,626 06/14/07 32,876 $ 8.8655 $ 291,462 06/15/07 32,876 $ 8.9674 $ 294,812 06/18/07 32,876 $ 8.8829 $ 292,034 06/19/07 9,862 $ 9.0777 $ 89,524 06/20 |
|
| August 7, 2007 |
Press Release SOURCE: eResearchTechnology, Inc. eResearchTechnology Reports Second Quarter 2007 Results eResearchTechnology Reports EPS of $0.08 vs. $0.03 in Q2 2006 Q2 Revenues Increase to $24.7 Million and New Bookings Increase to $34.5 Million PHILADELPHIA, August 2, 2007/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (eRT), (Nasdaq: ERES - News), a leading provider of centralized ECG and eC |
|
| August 7, 2007 |
e8vk Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 6, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2007 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file number 0 |
|
| August 3, 2007 |
corresp August 3, 2007 via Edgar Securities and Exchange Commission 100 F Street, N. |
|
| May 23, 2007 |
e8vkza UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A AMENDMENT NO. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 15, 2007 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of |
|
| May 4, 2007 |
EXHIBIT 10.12 ERESEARCHTECHNOLOGY, INC. 2007 BONUS PLAN Set forth below is a summary of the 2007 Bonus Plan approved by the Compensation Committee of the Board of Directors on February 15, 2007, to be effective for fiscal 2007. The purpose of the plan is to promote the interests of the Company and its stockholders by providing employees with financial rewards upon achievement of specified business |
